Similar articles

• Vascular outcome in type 2 diabetes: an ADVANCE?

  Kaplan NM. Kaplan NM. Lancet. 2007 Sep 8;370(9590):804-5. doi: 10.1016/S0140-6736(07)61304-X. Lancet. 2007. PMID: 17765962 Clinical Trial. No abstract available.
• Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.

  [No authors listed] [No authors listed] Cardiovasc J Afr. 2008 Jul-Aug;19(4):226. Cardiovasc J Afr. 2008. PMID: 18776973 No abstract available.
• [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].

  Nilsson PM. Nilsson PM. Lakartidningen. 2007 Oct 17-23;104(42):3028-9. Lakartidningen. 2007. PMID: 17985709 Swedish. No abstract available.
• Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.

  Gosse P. Gosse P. Expert Rev Cardiovasc Ther. 2006 May;4(3):319-33. doi: 10.1586/14779072.4.3.319. Expert Rev Cardiovasc Ther. 2006. PMID: 16716093 Review.
• The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.

  Waeber B, de la Sierra A, Ruilope LM. Waeber B, et al. Am J Cardiovasc Drugs. 2009;9(5):283-91. doi: 10.2165/10061600-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 19791837 Review.